26

2019-04


First Public Disclosure of the Environmental Impact Assessment for the R&D and Production Building Construction Project (Third Floor) of Beijing Minhai Biotechnology Co., Ltd.

(1) Project Name: Construction Project for the 13‑Valent Pneumococcal Conjugate Vaccine Workshop and the Acellular Pertussis (Component) Vaccine Bulk‑Drug Substance Workshop of Beijing Minhai Biotechnology Co., Ltd. (2) Site Location: The reserved workshop on the third floor of the R&D and Production Building at the Beijing Minhai Biotechnology Co., Ltd. within the Daxing Biopharmaceutical Industry Base of the Zhongguancun Science Park, Daxing District, Beijing.

23

2019-04


Public Opinion Form for the Environmental Impact Assessment of the R&D and Production Building Construction Project (Third Floor) of Beijing Minhai Biotechnology Co., Ltd.

Public Opinion Form for the Environmental Impact Assessment of the Construction Project: 13‑Valent Pneumococcal Conjugate Vaccine Workshop and Acellular Pertussis (Component) Vaccine Bulk‑Drug Substance Workshop, Beijing Minhai Biotechnology Co., Ltd. Date of Completion: Year Month Day Project Name: Construction Project of the 13‑Valent Pneumococcal Conjugate Vaccine Workshop and the Acellular Pertussis (Component) Vaccine Bulk‑Drug Substance Workshop, Beijing Minhai Biotechnology Co., Ltd. I. This page is intended to collect public comments and suggestions related to the environmental impacts of this project and its environmental protection measures. (Note: In accordance with the Measures on Public Participation in Environmental Impact Assessment, opinions or requests concerning land acquisition, relocation, property, employment, or other matters unrelated to the project’s environmental impact assessment are not within the scope of this project.)

< 123 >